What is FHTX's relative strength rating?

FHTX ranks at the 95th percentile over 1 month, 96th percentile over 3 months, 72th percentile over 6 months, 73th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is FHTX in?

FHTX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is FHTX in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). FHTX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is FHTX?

FHTX currently shows a 20-day average daily range (ADR%) of 8.2%, a 90-day beta versus the S&P 500 of 1.54. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does FHTX have a seasonal pattern?

TickerStance computes FHTX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what FHTX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did FHTX last report earnings?

FHTX most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-06. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Foghorn Therapeutics Inc. Common Stock (FHTX)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Foghorn Therapeutics Inc. Common Stock (FHTX) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.2%, relative volume 1.35×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month96pctile

6 month72pctile

1 year73pctile

Classic87IBD pctile

LDR95leadership

0 of 5 lenses lit · avg RS pctile 85

✓ADR%8.2%✓A/DA!RVOL1.35×!$ Vol$2M

COMPUTED · AS OF 2026-08-24

Pattern read

FHTX is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 28.9% / 36.2%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

4 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

95

3m

96

6m

72

1y

73

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D rating

Fundamentals · FHTX

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q2 · period end 2026-06-30

81

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,480 ranked stocks · Sector rank 83

View fundamental leadership map

Strong

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss narrowing

−$0.31—

24 Q3

−$0.23—

24 Q4

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
FHTX
96RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

BBIOBridgeBio Pharma, Inc. Common Stock72 NBIXNeurocrine Biosciences Inc72 ABOSAcumen Pharmaceuticals, Inc. Common Stock72 ACADAcadia Pharmaceuticals Inc.73

§ Seasonality

10y · since 2022

Best monthFeb on averageavg +31.23% · 50% win · n 4

Worst monthOct on averageavg -14.78% · 25% win · n 4

FHTX monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	FHTX Jan avg: -5.35% median: -2.74% win: 50% σ: 35.71% n: 4 2022-04-12 → 2026-07-31	FHTX Feb avg: 31.23% median: 7.61% win: 50% σ: 77.31% n: 4 2022-04-12 → 2026-07-31	FHTX Mar avg: -11.39% median: -14.52% win: 25% σ: 13.97% n: 4 2022-04-12 → 2026-07-31	FHTX Apr avg: -4.13% median: -0.63% win: 40% σ: 15.68% n: 5 2022-04-12 → 2026-07-31	FHTX May avg: 0.36% median: -2.86% win: 40% σ: 8.54% n: 5 2022-04-12 → 2026-07-31	FHTX Jun avg: 9.04% median: 11.92% win: 80% σ: 6.94% n: 5 2022-04-12 → 2026-07-31	FHTX Jul avg: 12.86% median: 11.70% win: 80% σ: 14.26% n: 5 2022-04-12 → 2026-07-31	FHTX Aug avg: -8.77% median: -10.49% win: 25% σ: 21.26% n: 4 2022-04-12 → 2026-07-31 (current)	FHTX Sep avg: -9.64% median: -8.52% win: 25% σ: 19.44% n: 4 2022-04-12 → 2026-07-31	FHTX Oct avg: -14.78% median: -13.98% win: 25% σ: 14.66% n: 4 2022-04-12 → 2026-07-31	FHTX Nov avg: 4.17% median: 6.28% win: 75% σ: 20.44% n: 4 2022-04-12 → 2026-07-31	FHTX Dec avg: 4.76% median: 4.10% win: 50% σ: 38.65% n: 4 2022-04-12 → 2026-07-31

ETF OWNERS

ETFs holding FHTX

FHTX is held by 12 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $753K notional. Top 3 carry $883K.

Held by 21 ETFs · $15M across latest filings · largest weight 0.04% (IWC).

ETFs holding: 12
Total value: $936K
Top 3 concentration: 94.3%
Max weight: IBBQ · 0.02%

Top 10 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding FHTX ranked by value
ETF	Weight	Value	Δ
VTWO	0.00%	$753K	—
VTWG	0.01%	$94K	—
VTWV	0.00%	$36K	—
IBBQ	0.02%	$13K	—
VTHRVanguard Russell 3000 ETF	0.00%	$10K	—
BIB

Public attention · FHTX

Is the crowd watching?

18/ 100 · vs its own 90-day norm▼ 40 vs 7dStealth leader

Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float33.8Mshares

Shares out59.4Mshares

Market cap$408.0MSmall Cap

FAQ

Frequently asked questions

What is FHTX's relative strength rating?: FHTX ranks at the 95th percentile over 1 month, 96th percentile over 3 months, 72th percentile over 6 months, 73th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is FHTX in?: FHTX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is FHTX in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). FHTX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is FHTX?: FHTX currently shows a 20-day average daily range (ADR%) of 8.2%, a 90-day beta versus the S&P 500 of 1.54. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does FHTX have a seasonal pattern?: TickerStance computes FHTX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what FHTX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Foghorn Therapeutics Inc. Common Stock (FHTX) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

ETFs holding FHTX

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

Foghorn Therapeutics Inc. Common Stock (FHTX) — Stance & relative strength

FHTX is on the watchlist, not confirmed. 3m RS is 96, Market Stance is mixed at 47.8, A/D rating A

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding FHTX

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?